Acumen Pharmaceuticals (ABOS) Shares Outstanding (2020 - 2026)

Acumen Pharmaceuticals' Shares Outstanding history runs 7 years deep, the most recent figure standing at $72.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 19.24% year-over-year to $72.2 million; the TTM figure through Mar 2026 stood at $72.2 million (up 19.24% YoY), while the FY2025 annual figure was $60.6 million, up 0.8% from the prior year.
• Shares Outstanding came in at $72.2 million for Q1 2026 at Acumen Pharmaceuticals, up from $60.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $72.2 million in Q1 2026 to a low of $40.5 million in Q1 2022.
• A 5-year average of $53.8 million and a median of $60.1 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding jumped 436.93% in 2022 and increased 0.8% in 2025, its largest moves.
• Acumen Pharmaceuticals' Shares Outstanding stood at $41.0 million in 2022, then surged by 41.16% to $57.9 million in 2023, then climbed by 3.77% to $60.1 million in 2024, then rose by 0.8% to $60.6 million in 2025, then increased by 19.24% to $72.2 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $72.2 million, $60.6 million, and $60.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison